We present an improved method for quantifying contrast agent uptake in highly desmoplastic pancreatic tumors in human patients. The new method separates the T1 and T2* effects of the Gadolinium-based contrast agent; uses fast acquisition and non-rigid registration to minimize motion effects; and two point Dixon imaging to separate the water component on a pixel by pixel basis.
This abstract and the presentation materials are available to members only; a login is required.